As of 2:30 PM on the 23rd, Jinwon Life Sciences is trading at 26,950 KRW, up 4.05% from the previous day. This is a 36.44% decrease compared to September 22. Jinwon Life Sciences is known as a company specializing in the development of gene therapies and gene vaccines.
Today, foreigners are tentatively recorded as net sellers of 152,000 shares. Over the past five days, individual investors have net sold 257,723 shares, while foreigners and institutions have net bought 281,399 shares and net sold 7,530 shares, respectively.
On October 22, Jinwon Life Sciences became an issue in the market with the headline "Decline due to institutional and foreign selling."
※ Source: AI Investment Assistant AI Rassiro
※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
